Evidence map›Paper›PMID 35790535›Full record

ArticleWorld journal of urology2022

The impact of 3D models on positive surgical margins after robot-assisted radical prostatectomy.

Enrico Checcucci, Angela Pecoraro, Daniele Amparore, Sabrina De Cillis, Stefano Granato, Gabriele Volpi, Michele Sica, Paolo Verri, Alberto Piana, Pietro Piazzolla and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 5 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 5 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Enrico CheccucciDepartment of Surgery, Candiolo Cancer Institute, FPO-IRCCS, Strada Provinciale 142, km 3, 95 10060, Candiolo, Turin, Italy. checcu.e@hotmail.it.ORCID http://orcid.org/0000-0001-7901-5608
Angela PecoraroDivision of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Daniele AmparoreDivision of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Sabrina De CillisDivision of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Stefano GranatoDivision of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Gabriele VolpiDivision of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Michele SicaDivision of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Paolo VerriDivision of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Alberto PianaDivision of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Pietro PiazzollaDepartment of Management and Production Engineer, Polytechnic University of Turin, Turin, Italy.
Matteo ManfrediDivision of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Enrico VezzettiDepartment of Management and Production Engineer, Polytechnic University of Turin, Turin, Italy.
Michele Di DioDivision of Urology, Department of Surgery, SS Annunziata Hospital, Cosenza, Italy.
Cristian Fiori *Division of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Francesco Porpiglia *Division of Urology, Department of Oncology, University of Turin San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
Uro-technology and SoMe Working Group of the Young Academic Urologists Working Party of the European Association of Urology
Ospedale San Luigi Gonzaga · ITPolitecnico di Torino · ITEuropean Association of Urology · NLOspedale Annunziata di Cosenza · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the role of 3D models on positive surgical margin rate (PSM) rate in patients who underwent robot-assisted radical prostatectomy (RARP) compared to a no-3D control group. Secondarily, we evaluated the postoperative functional and oncological outcomes.

methodsProspective study enrolling patients with localized prostate cancer (PCa) undergoing RARP with mp-MRI-based 3D model reconstruction, displayed in a cognitive or augmented-reality fashion, at our Centre from 01/2016 to 01/2020. A control no-3D group was extracted from the last two years of our Institutional RARP database. PSMr between the two groups was evaluated and multivariable linear regression (MLR) models were applied. Finally, Kaplan-Meier estimator was used to calculate biochemical recurrence at 12 months after the intervention.

results160 patients were enrolled in the 3D Group, while 640 were selected for the Control Group. A more conservative NS approach was registered in the 3D Group (full NS 20.6% vs 12.7%; intermediate NS 38.1% vs 38.0%; standard NS 41.2% vs 49.2%; p = 0.02). 3D Group patients had lower PSM rates (25 vs. 35.1%, p = 0.01). At MLR models, the availability of 3D technology (p = 0.005) and the absence of extracapsular extension (ECE, p = 0.004) at mp-MRI were independent predictors of lower PSMr. Moreover, 3D model represented a significant protective factor for PSM in patients with ECE or pT3 disease.

conclusionThe availability of 3D models during the intervention allows to modulate the NS approach, limiting the occurrence of PSM, especially in patients with ECE at mp-MRI or pT3 PCa.

Indexed as

Prostatic NeoplasmsRoboticsRobotic Surgical ProceduresHumansMaleMargins of ExcisionProspective StudiesProstatectomy3D modelingAugmented realityProstate cancerRobotic surgerySurgical margins

Identifiers

PMID35790535
OpenAlexW4284687753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.